Day One Agenda
Wednesday, April 24, 2024

8:00   REGISTRATION & WELCOME COFFEE

8:50   CHAIRPERSON’S OPENING REMARKS

9:00  KEYNOTE PANEL: 2024 INDUSTRY OUTLOOK ON THE EVOLVING MEDICAL COMMUNICATION ROLE
• Evolution of scientific and medical communications roles
• De-siloing departments for improved collaborative efficiency
• Examination of increased dependency on technology
        » Social media
        » AI & ML
•  Ideal data collection and advantageous use recommendations
Katie Chavanu, XERIS PHARMACEUTICALS
Ilia Antonino-Varriale, INTELLIA THERAPEUTICS
Heather Powell, ESPERION
Debra Mayo, OTSUKA
Shama Patel, CALLIDITAS THERAPEUTICS

9:45   CASE STUDY: STREAMLINING PROMOTIONAL REVIEW PROCESSES: A MEDICAL INFORMATION PERSPECTIVE
• Establishing a culture of compliance within medical information
• Developing submission guidelines to work in tandem with SOPs
• Software and automation tools to streamline MLR processes
Heather Powell, Senior Director, Integrated Evidence & Scientific Communication
ESPERION

10:30   COFFEE & NETWORKING BREAK

11:00  LEGAL PERSPECTIVE: CASE STUDY: COMPLIANT COMMUNICATIONS PERTAINING TO UNAPPROVED PRODUCT USAGE
• Examination and outcome expectations of latest FDA draft guidance document
• Clarifications of compliant factual vs. speculative information communications
        » Disease education
        » Product promotion
• Communicating additional possible product utilizations prior to approval
• Consideration of acceptable premarket deliverables for social media
James Boiani, Member of the Firm
EPSTEIN BECKER & GREEN

11:45   SMALL GROUP DISCUSSION: DE-SILOING DEPARTMENTS WHILE RETAINING BALANCE OF CLEARLY DEFINED RESPONSIBILITIES
With the consideration of constantly shifting roles and responsibilities within medical and scientific communications, being able to de-silo and work closely with colleagues in parallel departments is the key to developing a more cooperative and efficient working environment. This interactive discussion will break the audience into self-determined groups to discuss potential strategies to implement for improved collaboration across departments without sacrificing clear-cut task management.
Ilia Antonino-Varriale, Sr. Director, Head of External Medical Communications
INTELLIA THERAPEUTICS

12:30   LUNCHEON FOR ALL SPEAKERS, SPONSORS & ATTENDEES

1:30 CASE STUDY: FRAMEWORKS FOR EFFECTIVE DATA COLLECTION UTILIZING A FUNDAMENTAL OMNICHANNEL SYSTEM
• Breakdown of critical components necessary within omnichannel systems
• Essential considerations for tailor-made omnichannel frameworks
• Scaling omnichannel strategies for various market focus requirements
        » Regional level
        » Global level
• Significant inclusion of additional data sources beyond omnichannel
Ashwini Dhume, Head Scientific Communication Solid Tumor – US Oncology
JOHNSON & JOHNSON

2:15  CASE STUDY: CREATING DASHBOARDS FOR TRACKING ACCOMPLISHMENT OF COMMUNICATION AND GOALS
• Determining critical metrics for live dashboard incorporation and access
• Existing dashboard platforms available for straightforward implementation
• Inclusion of management tracking for broader view of overall success
Debra Mayo, Executive Director Global Medical Communications & Operations
OTSUKA

3:00  COFFEE & NETWORKING BREAK

3:30   PANEL DISCUSSION: EVOLUTION OF MEDICAL COMMUNICATION EMPLOYMENT TRENDS
• Evaluating current shifts in employment trends within life sciences industry
• Frameworks for maintaining capabilities in light of team fluctuations
• Developing continually updated trainings and onboarding procedures
• Considerations for adapting to rise in interest of consultation positions
Joanna Rega, INSMED INCORPORATED
Radha Narayan, ALEXION, ASTRAZENECA RARE DISEASE
Whitney Hauser, DOMPÉ
Usha Iyer, TAKEDA

4:15  CASE STUDY: IMPROVED COMPLIANCE AND QUALITY FOR COMMUNICATIONS SUPPORTED PUBLICATIONS PRACTICES
• Managing author inclusion on required communication documents
        » International authors
        » Patients as authors
• Publication recommendation updates post-2022 implementations
        » ICMJE
        » ISMPP
• Establishing baseline knowledge of publication practices for collaboration
Dikran Toroser, Sr. Director, Publications Group Lead
MERCK & CO.

5:oo   Closing Remarks & End of Day 1

Day Two Agenda
Thursday, April 25, 2024

8:00   REGISTRATION & WELCOME COFFEE

8:20   CHAIRPERSON’S OPENING REMARKS

CHAPTER: ARTIFICIAL INTELLIGENCE & MACHINE LEARNING PERSPECTIVE ADVANTAGES AND EXPECTED LIMITATIONS

8:30   CASE STUDY: MASTERY OF AI & ML  FOR IMPROVED EFFICIENCY AND METRIC TRACKING
• Identifying key differences between capabilities of AI & ML software
• Navigating available AI & ML platforms for effective application
• Strategies for prospective integration of omnichannel environments
Whitney Hauser, Sr. Director, Global Medical Communications
DOMPÉ

9:15   LEGAL PERSPECTIVE: CURRENT AI & ML REGULATORY AND USE RESTRICTIONS
• Discerning realities of present cognitive computing limitations
• Verbiage to utilize when referring to AI and ML within publications
• Ensuring legal compliance when pursuing AI and ML implementation
Jacqueline Cooney, Partner
ARNALL GOLDEN GREGORY LLP

10:00   COFFEE & NETWORKING BREAK

10:30 CASE STUDY: ESTABLISHING AND MAINTAINING EFFECTIVE COMMUNICATION WITH EXTERNAL VENDORS
• Early collaboration of development processes for improved productivity
• Conveying legal and regulatory requirements for review efficiency
• Agreement on acceptable product expectations and verbiage usages
Jessica Monteith, Senior Manager, Medical Communications
BRACCO DIAGNOSTICS

11:15   SESSION SERIES: NAVIGATING DIVERSE STAKEHOLDER INFORMATION EXPECTATIONS & COMMUNICATION STYLES
With rising expectations in techniques used to gather and distribute accurate information, challenges have become more apparent in identifying apt communication methods with stakeholders. This session series will provide various perspectives of patients, HCPs, and MSLs to determine the most effective approaches in creating appropriately tailored messaging within deliverables.
SESSION FOCUS:  Patients
Radha Narayan, Director of Global Medical Communications
ALEXION, ASTRAZENECA RARE DISEASE

12:00  LUNCHEON FOR ALL SPEAKERS, SPONSORS & ATTENDEES

1:00 SESSION SERIES: NAVIGATING DIVERSE STAKEHOLDER INFORMATION EXPECTATIONS & COMMUNICATION STYLES
With rising expectations in techniques used to gather and distribute accurate information, challenges have become more apparent in identifying apt communication methods with stakeholders. This session series will provide various perspectives of patients, HCPs, and MSLs to determine the most effective approaches in creating appropriately tailored messaging within deliverables.
SESSION FOCUS: HCPs
Daina Nanchanatt, Director, Oncology Scientific Communication
BAYER

1:45 SESSION SERIES: NAVIGATING DIVERSE STAKEHOLDER INFORMATION EXPECTATIONS & COMMUNICATION STYLES
With rising expectations in techniques used to gather and distribute accurate information, challenges have become more apparent in identifying apt communication methods with stakeholders. This session series will provide various perspectives of patients, HCPs, and MSLs to determine the most effective approaches in creating appropriately tailored messaging within deliverables.
SESSION FOCUS: MSLs
Katie Chavanu, Vice President of Medical Communications and Regional Medical Affairs
XERIS PHARMACEUTICALS

2:30   COFFEE & NETWORKING BREAK

3:00  SMALL GROUP DISCUSSION: INCREASING MEDICAL AND SCIENTIFIC COMMUNICATION INFLUENCE IN SUPPORT OF PRODUCT PIPELINES
• Transforming KPIs into impactful pipeline advice for diverse product lines
• Medical communication strengths crucial for product lifecycle influence
• Understanding regulatory considerations that may impact medical communications
Monica Ramchandani, PhD, Director, Scientific Communications
GILEAD SCIENCES

3:45 CASE STUDY: COMPLIANT STRATEGIC APPROACHES FOR INCREASED SOCIAL MEDIA COMMUNICATION ENGAGEMENT
• Explicit US regulatory specifications for social media exchanges
• Supplemental proposed social media interaction guidelines
        » Posting verbiage
        » Reposting and sharing
        » Liking and commenting
• Aligning social media platform use with communication outreach goals
Matthew Wadyka, Global Head Scientific Communications
GENENTECH

4:30   Closing Remarks & Conference Conclusion